Orlando Magic · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 25.4 | 6.0 | 7.0 | 1.0 | 14.0 | 0.0 | 1.3 | 1.0 | 2.0 | 4.3 |
| 46.2% |
| 0.0 |
| 1.3 |
| 0.0% |
| 2.0 |
| 3.3 |
| 60.0% |
| Last 5 | 5 | 25.3 | 8.6 | 5.8 | 1.4 | 15.8 | 0.2 | 0.8 | 1.0 | 2.6 | 4.2 | 61.9% | 0.2 | 1.4 | 14.3% | 2.8 | 4.4 | 63.6% |
| Last 10 | 10 | 27.7 | 11.4 | 6.8 | 1.1 | 19.3 | 0.5 | 0.6 | 1.7 | 3.2 | 5.4 | 59.3% | 0.4 | 1.6 | 25.0% | 3.8 | 4.9 | 77.6% |
| Last 20 | 20 | 28.5 | 12.6 | 6.8 | 1.8 | 21.1 | 0.8 | 0.6 | 1.4 | 3.6 | 5.6 | 64.9% | 0.7 | 2.1 | 30.2% | 3.4 | 4.3 | 78.2% |
| Season | 78 | 29.3 | 11.8 | 7.4 | 2.0 | 21.2 | 0.8 | 0.6 | 1.3 | 3.3 | 5.3 | 61.8% | 0.9 | 2.9 | 31.9% | 2.5 | 3.2 | 79.2% |
high post-ups, high contested shots per minute, high rim finishing off the ball, high offensive rebounding
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | ORL @ BOS | L | 31.1 | 3 | 8 | 2 | 0 | 2 | 2 | 0 | 5 | 0.0% | 0 | 2 | 0.0% | 3 | 4 | 75.0% | -4.0 |
| 2026-04-10 | ORL @ CHI | W | 25.4 | 11 | 6 | 0 | 0 | 1 | 0 | 4 | 7 | 57.1% | 0 | 1 | 0.0% | 3 | 4 | 75.0% | 19.0 |
| 2026-04-08 | ORL vs. MIN | W | 19.6 | 4 | 7 | 1 | 0 | 1 | 1 | 2 | 5 | 40.0% | 0 | 1 | 0.0% | 0 | 2 | 0.0% | 1.0 |
| 2026-04-06 | ORL vs. DET | W | 18.4 | 12 | 3 | 3 | 1 | 0 | 1 | 2 | 4 | 50.0% | 1 | 2 | 50.0% | 7 | 8 | 87.5% | 26.0 |
| 2026-04-05 | ORL @ NOP | W | 31.8 | 13 | 5 | 1 | 0 | 0 | 1 | 6 | 7 | 85.7% | 0 | 1 | 0.0% | 1 | 4 | 25.0% | -5.0 |
| 2026-04-03 | ORL @ DAL | W | 35.9 | 28 | 6 | 3 | 0 | 0 | 2 | 8 | 16 | 50.0% | 2 | 3 | 66.7% | 10 | 10 | 100.0% | 6.0 |
| 2026-04-01 | ORL vs. ATL | L | 25.1 | 14 | 6 | 0 | 1 | 1 | 1 | 6 | 9 | 66.7% | 0 | 2 | 0.0% | 2 | 2 | 100.0% | -16.0 |
| 2026-03-31 | ORL vs. PHX | W | 28.4 | 15 | 12 | 0 | 2 | 0 | 6 | 4 | 7 | 57.1% | 1 | 1 | 100.0% | 6 | 7 | 85.7% | 6.0 |
| 2026-03-29 | ORL @ TOR | L | 25.8 | 4 | 4 | 1 | 0 | 0 | 1 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | -23.0 |
| 2026-03-26 | ORL vs. SAC | W | 35.4 | 10 | 11 | 0 | 1 | 1 | 2 | 3 | 8 | 37.5% | 0 | 2 | 0.0% | 4 | 6 | 66.7% | 0.0 |
| 2026-03-24 | ORL @ CLE | L | 29.2 | 15 | 5 | 2 | 1 | 1 | 0 | 4 | 7 | 57.1% | 2 | 5 | 40.0% | 5 | 6 | 83.3% | -3.0 |
| 2026-03-23 | ORL vs. IND | L | 28.1 | 17 | 5 | 2 | 1 | 0 | 2 | 7 | 11 | 63.6% | 0 | 2 | 0.0% | 3 | 3 | 100.0% | -6.0 |
| 2026-03-21 | ORL vs. LAL | L | 29.1 | 13 | 9 | 2 | 1 | 0 | 1 | 5 | 8 | 62.5% | 1 | 1 | 100.0% | 2 | 2 | 100.0% | -11.0 |
| 2026-03-17 | ORL vs. OKC | L | 28.9 | 11 | 5 | 3 | 1 | 0 | 1 | 3 | 9 | 33.3% | 0 | 4 | 0.0% | 5 | 6 | 83.3% | 19.0 |
| 2026-03-16 | ORL @ ATL | L | 28.2 | 17 | 3 | 1 | 1 | 0 | 2 | 6 | 10 | 60.0% | 2 | 5 | 40.0% | 3 | 3 | 100.0% | -17.0 |
| 2026-03-14 | ORL @ MIA | W | 34.8 | 15 | 8 | 2 | 0 | 0 | 1 | 5 | 8 | 62.5% | 1 | 3 | 33.3% | 4 | 4 | 100.0% | 7.0 |
| 2026-03-12 | ORL vs. WAS | W | 33.8 | 19 | 11 | 3 | 2 | 2 | 2 | 8 | 13 | 61.5% | 2 | 3 | 66.7% | 1 | 2 | 50.0% | 13.0 |
| 2026-03-11 | ORL vs. CLE | W | 35.4 | 11 | 11 | 4 | 0 | 1 | 0 | 4 | 7 | 57.1% | 1 | 3 | 33.3% | 2 | 6 | 33.3% | 7.0 |
| 2026-03-08 | ORL @ MIL | W | 21.6 | 9 | 5 | 2 | 2 | 1 | 1 | 3 | 6 | 50.0% | 0 | 1 | 0.0% | 3 | 4 | 75.0% | 20.0 |
| 2026-03-07 | ORL @ MIN | W | 24.8 | 10 | 6 | 3 | 1 | 1 | 1 | 4 | 5 | 80.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 16.0 |
| 2026-03-05 | ORL vs. DAL | W | 23.6 | 15 | 7 | 1 | 1 | 1 | 0 | 5 | 6 | 83.3% | 1 | 1 | 100.0% | 4 | 4 | 100.0% | 8.0 |
| 2026-03-01 | ORL vs. DET | L | 32.8 | 4 | 9 | 2 | 2 | 1 | 2 | 2 | 6 | 33.3% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -18.0 |
| 2026-02-26 | ORL vs. HOU | L | 27.1 | 16 | 6 | 1 | 0 | 0 | 1 | 6 | 8 | 75.0% | 1 | 1 | 100.0% | 3 | 6 | 50.0% | -4.0 |
| 2026-02-24 | ORL @ LAL | W | 35.9 | 20 | 11 | 2 | 0 | 0 | 1 | 9 | 13 | 69.2% | 0 | 2 | 0.0% | 2 | 2 | 100.0% | 0.0 |
| 2026-02-22 | ORL @ LAC | W | 33.3 | 15 | 14 | 3 | 0 | 0 | 5 | 6 | 14 | 42.9% | 0 | 1 | 0.0% | 3 | 3 | 100.0% | 2.0 |
| 2026-02-21 | ORL @ PHX | L | 34.3 | 7 | 11 | 1 | 0 | 0 | 2 | 2 | 4 | 50.0% | 0 | 2 | 0.0% | 3 | 3 | 100.0% | 19.0 |
| 2026-02-19 | ORL @ SAC | W | 24.8 | 2 | 8 | 3 | 1 | 0 | 0 | 1 | 5 | 20.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 10.0 |
| 2026-02-11 | ORL vs. MIL | L | 30.6 | 6 | 11 | 3 | 2 | 0 | 1 | 1 | 7 | 14.3% | 0 | 3 | 0.0% | 4 | 4 | 100.0% | -8.0 |
| 2026-02-09 | ORL vs. MIL | W | 24.3 | 4 | 8 | 2 | 2 | 0 | 0 | 2 | 8 | 25.0% | 0 | 4 | 0.0% | 0 | 0 | 0.0% | -1.0 |
| 2026-02-07 | ORL vs. UTA | W | 28.4 | 8 | 6 | 1 | 1 | 1 | 2 | 2 | 3 | 66.7% | 0 | 1 | 0.0% | 4 | 4 | 100.0% | 7.0 |
| 2026-02-05 | ORL vs. BKN | W | 21.8 | 7 | 8 | 1 | 2 | 1 | 1 | 3 | 6 | 50.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 10.0 |
| 2026-02-03 | ORL @ OKC | L | 23.4 | 9 | 7 | 2 | 1 | 0 | 1 | 3 | 7 | 42.9% | 1 | 3 | 33.3% | 2 | 2 | 100.0% | -13.0 |
| 2026-02-01 | ORL @ SAS | L | 19.4 | 2 | 2 | 0 | 2 | 0 | 0 | 1 | 7 | 14.3% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -24.0 |
| 2026-01-30 | ORL vs. TOR | W | 34.9 | 23 | 7 | 3 | 1 | 0 | 0 | 9 | 14 | 64.3% | 2 | 4 | 50.0% | 3 | 3 | 100.0% | 23.0 |
| 2026-01-28 | ORL @ MIA | W | 27.0 | 10 | 5 | 1 | 0 | 0 | 1 | 4 | 8 | 50.0% | 2 | 5 | 40.0% | 0 | 0 | 0.0% | 6.0 |
| 2026-01-26 | ORL @ CLE | L | 33.5 | 9 | 7 | 1 | 0 | 1 | 0 | 4 | 8 | 50.0% | 1 | 4 | 25.0% | 0 | 0 | 0.0% | -13.0 |
| 2026-01-24 | ORL vs. CLE | L | 29.8 | 11 | 5 | 3 | 1 | 2 | 3 | 3 | 9 | 33.3% | 1 | 5 | 20.0% | 4 | 4 | 100.0% | -2.0 |
| 2026-01-22 | ORL vs. CHA | L | 20.0 | 4 | 3 | 3 | 1 | 0 | 0 | 2 | 6 | 33.3% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -10.0 |
| 2026-01-18 | ORL @ MEM | L | 33.0 | 18 | 7 | 4 | 2 | 2 | 1 | 6 | 11 | 54.5% | 4 | 7 | 57.1% | 2 | 2 | 100.0% | -15.0 |
| 2026-01-15 | ORL @ MEM | W | 28.5 | 9 | 6 | 3 | 0 | 1 | 1 | 3 | 7 | 42.9% | 1 | 4 | 25.0% | 2 | 2 | 100.0% | 13.0 |
| 2026-01-09 | ORL vs. PHI | L | 28.9 | 13 | 8 | 2 | 0 | 3 | 4 | 6 | 13 | 46.2% | 1 | 6 | 16.7% | 0 | 0 | 0.0% | 3.0 |
| 2026-01-07 | ORL @ BKN | W | 39.4 | 20 | 6 | 3 | 1 | 1 | 1 | 8 | 14 | 57.1% | 0 | 4 | 0.0% | 4 | 5 | 80.0% | -6.0 |
| 2026-01-06 | ORL @ WAS | L | 19.6 | 2 | 7 | 3 | 0 | 0 | 1 | 1 | 6 | 16.7% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -19.0 |
| 2026-01-04 | ORL vs. IND | W | 31.5 | 18 | 12 | 4 | 2 | 0 | 1 | 6 | 10 | 60.0% | 1 | 3 | 33.3% | 5 | 8 | 62.5% | 12.0 |
| 2026-01-02 | ORL @ CHI | L | 31.8 | 13 | 10 | 1 | 0 | 0 | 0 | 4 | 12 | 33.3% | 2 | 6 | 33.3% | 3 | 5 | 60.0% | 7.0 |
| 2025-12-31 | ORL @ IND | W | 28.9 | 6 | 11 | 2 | 0 | 0 | 0 | 1 | 4 | 25.0% | 0 | 2 | 0.0% | 4 | 6 | 66.7% | -1.0 |
| 2025-12-29 | ORL @ TOR | L | 31.7 | 9 | 6 | 2 | 1 | 1 | 1 | 4 | 10 | 40.0% | 1 | 5 | 20.0% | 0 | 0 | 0.0% | 4.0 |
| 2025-12-27 | ORL vs. DEN | W | 37.8 | 18 | 7 | 4 | 0 | 0 | 0 | 8 | 16 | 50.0% | 1 | 4 | 25.0% | 1 | 2 | 50.0% | -18.0 |
| 2025-12-26 | ORL vs. CHA | L | 28.3 | 16 | 8 | 1 | 1 | 1 | 1 | 5 | 10 | 50.0% | 2 | 5 | 40.0% | 4 | 4 | 100.0% | -4.0 |
| 2025-12-23 | ORL @ POR | W | 30.8 | 14 | 7 | 1 | 1 | 1 | 0 | 5 | 11 | 45.5% | 1 | 4 | 25.0% | 3 | 3 | 100.0% | 7.0 |
| 2025-12-22 | ORL @ GSW | L | 28.7 | 9 | 4 | 2 | 0 | 0 | 1 | 3 | 8 | 37.5% | 0 | 3 | 0.0% | 3 | 4 | 75.0% | -1.0 |
| 2025-12-20 | ORL @ UTA | W | 37.5 | 14 | 9 | 4 | 0 | 1 | 2 | 6 | 9 | 66.7% | 1 | 3 | 33.3% | 1 | 2 | 50.0% | -1.0 |
| 2025-12-18 | ORL @ DEN | L | 28.6 | 26 | 8 | 0 | 1 | 2 | 0 | 11 | 15 | 73.3% | 4 | 7 | 57.1% | 0 | 0 | 0.0% | 7.0 |
| 2025-12-13 | ORL @ NYK | L | 35.4 | 14 | 6 | 2 | 4 | 0 | 0 | 4 | 6 | 66.7% | 2 | 2 | 100.0% | 4 | 6 | 66.7% | 3.0 |
| 2025-12-09 | ORL vs. MIA | W | 30.9 | 14 | 10 | 3 | 1 | 1 | 0 | 6 | 8 | 75.0% | 2 | 3 | 66.7% | 0 | 0 | 0.0% | -2.0 |
| 2025-12-07 | ORL @ NYK | L | 33.5 | 8 | 7 | 3 | 0 | 0 | 0 | 2 | 8 | 25.0% | 1 | 5 | 20.0% | 3 | 4 | 75.0% | -3.0 |
| 2025-12-05 | ORL vs. MIA | W | 27.5 | 7 | 7 | 1 | 0 | 0 | 0 | 3 | 5 | 60.0% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | -10.0 |
| 2025-12-03 | ORL vs. SAS | L | 28.6 | 5 | 9 | 2 | 1 | 1 | 1 | 2 | 9 | 22.2% | 0 | 4 | 0.0% | 1 | 2 | 50.0% | -12.0 |
| 2025-12-01 | ORL vs. CHI | W | 30.3 | 17 | 6 | 1 | 1 | 1 | 0 | 6 | 8 | 75.0% | 1 | 2 | 50.0% | 4 | 6 | 66.7% | -1.0 |
| 2025-11-28 | ORL @ DET | W | 32.2 | 8 | 11 | 3 | 1 | 1 | 3 | 2 | 7 | 28.6% | 2 | 4 | 50.0% | 2 | 2 | 100.0% | 7.0 |
| 2025-11-25 | ORL @ PHI | W | 21.8 | 12 | 8 | 1 | 0 | 0 | 1 | 4 | 5 | 80.0% | 0 | 1 | 0.0% | 4 | 4 | 100.0% | 33.0 |
| 2025-11-22 | ORL vs. NYK | W | 21.9 | 11 | 4 | 1 | 0 | 0 | 2 | 4 | 4 | 100.0% | 2 | 2 | 100.0% | 1 | 2 | 50.0% | 7.0 |
| 2025-11-20 | ORL vs. LAC | W | 31.7 | 7 | 7 | 6 | 1 | 0 | 0 | 3 | 11 | 27.3% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 13.0 |
| 2025-11-18 | ORL vs. GSW | W | 35.1 | 17 | 12 | 2 | 1 | 0 | 1 | 5 | 7 | 71.4% | 1 | 3 | 33.3% | 6 | 6 | 100.0% | -1.0 |
| 2025-11-16 | ORL @ HOU | L | 37.4 | 15 | 6 | 2 | 1 | 4 | 1 | 5 | 11 | 45.5% | 2 | 4 | 50.0% | 3 | 4 | 75.0% | 3.0 |
| 2025-11-14 | ORL vs. BKN | W | 31.8 | 7 | 5 | 3 | 0 | 0 | 2 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 5 | 5 | 100.0% | 11.0 |
| 2025-11-12 | ORL @ NYK | W | 31.4 | 13 | 8 | 2 | 0 | 0 | 4 | 6 | 8 | 75.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -3.0 |
| 2025-11-10 | ORL vs. POR | W | 29.7 | 19 | 9 | 5 | 0 | 2 | 4 | 8 | 12 | 66.7% | 1 | 3 | 33.3% | 2 | 2 | 100.0% | 2.0 |
| 2025-11-09 | ORL vs. BOS | L | 31.8 | 12 | 4 | 1 | 1 | 1 | 3 | 4 | 10 | 40.0% | 2 | 6 | 33.3% | 2 | 2 | 100.0% | -3.0 |
| 2025-11-07 | ORL vs. BOS | W | 31.1 | 18 | 5 | 1 | 2 | 0 | 3 | 5 | 10 | 50.0% | 2 | 4 | 50.0% | 6 | 7 | 85.7% | 10.0 |
| 2025-11-04 | ORL @ ATL | L | 30.0 | 11 | 5 | 1 | 0 | 0 | 0 | 4 | 8 | 50.0% | 1 | 4 | 25.0% | 2 | 2 | 100.0% | -7.0 |
| 2025-11-01 | ORL @ WAS | W | 28.0 | 16 | 12 | 0 | 0 | 2 | 2 | 7 | 10 | 70.0% | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 26.0 |
| 2025-10-30 | ORL @ CHA | W | 26.9 | 18 | 8 | 3 | 0 | 1 | 1 | 6 | 9 | 66.7% | 3 | 5 | 60.0% | 3 | 4 | 75.0% | 10.0 |
| 2025-10-29 | ORL @ DET | L | 15.2 | 8 | 2 | 1 | 0 | 0 | 2 | 3 | 3 | 100.0% | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 2.0 |
| 2025-10-27 | ORL @ PHI | L | 34.0 | 10 | 10 | 2 | 1 | 2 | 2 | 4 | 11 | 36.4% | 1 | 2 | 50.0% | 1 | 3 | 33.3% | -19.0 |
| 2025-10-25 | ORL vs. CHI | L | 31.0 | 8 | 13 | 1 | 1 | 0 | 2 | 1 | 7 | 14.3% | 1 | 2 | 50.0% | 5 | 6 | 83.3% | 6.0 |
| 2025-10-24 | ORL vs. ATL | L | 31.1 | 10 | 8 | 2 | 2 | 0 | 2 | 2 | 4 | 50.0% | 0 | 1 | 0.0% | 6 | 11 | 54.5% | -10.0 |
| 2025-10-22 | ORL vs. MIA | W | 29.5 | 9 | 8 | 1 | 1 | 1 | 2 | 2 | 5 | 40.0% | 0 | 1 | 0.0% | 5 | 5 | 100.0% | -7.0 |